A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the ...
Inhibikase Therapeutics said on Wednesday it would stop development of its experimental Parkinson's disease drug after it failed to improve patients' ability to carry out daily tasks such as eating ...
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
"Now that we know how Aplp1 and Lag3 interact, we have a new way of understanding how alpha-synuclein contributes to the ...
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Studies in primate models and patients with Parkinson's disease have shown that ... or by modifying the pharmacokinetic profile of the drug by administering it in combination with a catechol ...
Sleep problems are very common in people with Parkinson’s disease and are associated with poorer quality of life in patients, ...